Cargando...

Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis

Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Parasit Dis
Main Authors: Rashidi, Sajad, Kalantar, Kurosh, Hatam, Gholamreza
Formato: Artigo
Idioma:Inglês
Publicado: Springer India 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/
https://ncbi.nlm.nih.gov/pubmed/29844618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!